A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma
Clinical trial NCT01677390 · TERMINATED
Trial details
- NCT number
- NCT01677390
- Sponsor
- Seagen Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-12-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.